Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04510636
Status:
RECRUITING
Last Update Posted:
2024-03-22
First Post:
2020-08-09
Brief Title:
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-09
First Submit QC Date:
August 9 2020
Study First Post Date:
2020-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-20
Last Update Post Date:
2024-03-22
Last Update Post Date Type:
ACTUAL